# Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry

> **NCT05880537** · — · RECRUITING · sponsor: **LifeNet Health** · enrollment: 100 (estimated)

## Conditions studied

- End-Stage Renal Disease

## Interventions

- **OTHER:** Nexeon Arterial Venous Allograft

## Key facts

- **NCT ID:** NCT05880537
- **Lead sponsor:** LifeNet Health
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-06
- **Primary completion:** 2027-12-15
- **Final completion:** 2027-12-15
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05880537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05880537, "Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05880537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*